… risk of ovariancancer among low-dose aspirin users and an increased risk of ovariancancer … Table 2.4 Association of urinaryPGE-Mlevels and risk of ovariancancer in NHS, NHSII …
… risk factor of aggressive prostate cancer, this study aimed to identify if elevated urinaryPGE-M levels … However, this relationship was not observed in ovariancancer [18], and our results …
Q Cai, YT Gao, WH Chow, XO Shu, G Yang… - Journal of Clinical …, 2006 - ascopubs.org
… In this study, we evaluated the association of urinaryPGE-Mlevels and colorectal cancer risk in the Shanghai Women's Health Study (SWHS), a large population-based, prospective …
… PGE-Mlevels using LC/MS methods, and used the PGE-M … urinaryPGE-M (in tertiles) and risk of ovariancancer using … lower risk of ovariancancer for those with the highest PGE-M …
W Wen, G Yang, Q Cai, XO Shu, W Zheng - Scientific Reports, 2022 - nature.com
… , we obtained urinaryPGE-Mlevels of 2927 non-… urinaryPGE-M were obtained from the parent cohort studies. Using linear regression models, we found that high urinaryPGE-Mlevels …
S Kim, J Campbell, W Yoo, JA Taylor… - Cancer Epidemiology …, 2017 - AACR
… in our cohort, but was not associated with either urinaryPGE-M or EM levels. We thus … among PGE-M, EM, and breast cancerrisk. In conclusion, we found that urinarylevels of E2, but no …
PG Smith, D Roque, MM Ching, A Fulton… - Frontiers in …, 2020 - frontiersin.org
… levels of 8-HETE produced by 8-LOX and other free fatty acid metabolites were at higher risk of developing ovariancancer … Similarly, urinaryPGE-Mlevels were elevated in HIV positive …
M Kiely, GL Milne, TZ Minas, TH Dorsey, W Tang… - 2021 - researchgate.net
… This pattern is not universally described, however, and a null association has been reported for ovariancancer [18]. Additionally, the use of the COX-2-specific inhibitor, celecoxib, did …
DA Drew, MM Schuck, MV Magicheva-Gupta… - Cancer Prevention …, 2020 - AACR
… By examining the change from baseline urinaryPGE-Mlevels in at-risk individuals, our study provides an opportunity to understand personalized responses to aspirin intervention. …